Dexmedetomidine for Sedation of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Status:
Completed
Trial end date:
2020-01-22
Target enrollment:
Participant gender:
Summary
Preventing hypoxemia is one of the major goal of studies for bronchoscopic sedation.
Dexmedetomidine is a sedative agents via α2 adrenergic agonist, with little respiratory
suppression. In the preset study, we evaluate the safety and feasibility of the
Dexmedetomidine in the specific bronchoscopic procedure, endobronchial ultrasound
(EBUS)-guided transbronchial needle aspiration.